Biotech/New Drugs

Aravive (Nasdaq: ARAV)
A first-in-class biologic drug, an AXL-Fc fusion protein which acts as a trap for Gas6 AXL signaling which plays an important role tumor metastasis and associated EMT mechanism.
A first-in-class biologic drug targeting an important innate immunity pathway, CD24 Siglec signaling.
OncoC4 is a clinical stage immuno-oncology company founded by prominent immunologist Prof. Yang Liu. Company develops Best-in-class CTLA-4 antibody and First-in-class CD24 antibody.
C4 Therapeutics (Nasdaq: CCCC)
C4T is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell.
A first-in-class and best-in-class antibody drug that targets immuno-oncology target CD40.
A first-in-class small molecule drug targeting LAT1, large amino acid transporter protein.
Immune-Onc Therapeutics
A first-in-class antibody drug targeting an immune inhibitory receptor LILRB4, for the treatment of M4 M5 type of AML.
Next Generation ”Gene-Therapy” Drug Delivery Platform, initially targeting chronic eye diseases, expandable to other broader indications.
Clinical-stage pharmaceutical company discovering and developing disease modifying treatments for neuropathy with first indication of diabetic neuropathy.
A tumor microenvironment targeted preclinical company with first focus on developing anti-CD39 humanized antibody drug with new MOA and drug design.
A first-in-class biologic that treats PIV induced hospitalized pneumonia via targeting the host cell surface receptor.
To utilize our revolutionary and proprietary targeted protein degradation technology to create, in a highly efficient manner, new drugs for treatment of diseases that currently lack effective therapies.
SHANTON is a biotechnology research organization established in 2016 and key areas of interest focus on uric acid metabolism, inflammatory pain, and gout metabolic syndrome diseases.
Lipidio is focused on advancing a molecule to treat diseases associated with excess body fat including non-alcoholic steatohepatitis (NASH), Prader-Willi syndrome (PWS) and antipsychotic drug-induced weight gain (AIWG), which represent major unmet medical
Cognition Therapeutics (Nasdaq: CGTX)
TREATING CENTRAL NERVOUS SYSTEM DISORDERS by targeting the cellular damage response mechanism​​s
Myro Therapeutics
Develop first-in-class and best-in-class small molecule drugs for neuroimmune, demyelinating, neurodegenerative, and neuropsychiatric disorders.
A private pharmaceutical company with a therapeutic focus on dermatology, founded in 2021 through a spin-off from Novaliq GmbH.
Dewpoint Therapeutics
Translate Condensate Biology into Breakthrough Medicine
To kill and eliminate cancer cells in patients by activating the immune cells.

X-Disciplinary HealthTech

Twist (Nasdaq: TWST)
Revolutionary silicon-based platform to enable high-throughput, rapid, precise and cost-effective DNA synthesis, potentially applicable in broad fields including healthcare, industrial chemicals, agriculture.
Cytek(Nasdaq: CTKB)
A transformative new flow cytometer platform company, replacing traditional filter with optical grating, and PMT with APD.
A revolutionary new biosensor platform that supports non-invasive continuous blood chemistry monitoring, including O2, Glucose, PH, lactate etc.
The world leader in the next generation of semiconductor ultrasound technology. Its MEMS-based CMUT technology achieves a higher resolution while significantly reducing the cost.
Disruptive digital Elisa protein-detection platform with ultra-high sensitivity, throughput and dynamic range.
Subtle Medical
The first AI solutions, FDA cleared for medical imaging enhancement Faster, Safer, Smarter
Bayland Scientific
Bayland Scientific provides patients with world-class care to detect and monitor cardiac abnormalities through in-clinic and at-home telemedicine.
Neural Galaxy
Born out of Harvard Medical School and MIT McGovern Institute for Brain Research, Neural Galaxy aims to help solve one of the biggest challenges facing mankind: brain disorders.
Alveo Technologies
A rapid, multiplexed molecular diagnostic platform for Flu, COVID-19, and RSV
Sentieon® develops and supplies a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, exceptional accuracy, and 100% consistency.